Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Açın
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1.091,51
-2,30
-0,21%
—1.093,811.096,521.100,221.091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1.237,98
-16,83
-1,34%
—1.254,811.253,011.253,871.226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1.744,71
-16,40
-0,93%
—1.761,111.764,271.766,881.744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3.260,69
+48,86
+1,52%
—3.211,833.227,213.268,383.226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1.466,80
-7,72
-0,52%
—1.474,521.479,031.481,041.466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2.397,50
+5,38
+0,22%
—2.392,122.396,952.421,222.382,32——
IGC:NYSEAMERICAN
IGC Pharma Inc
0,33 US$
+5,41%
(+0,017) 1D
0,33 US$
-1,46% (-0,0049)
After hours
Closed: 1 may, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IGC...
Açın
0,32 US$
High
0,34 US$
Low
0,32 US$
Mkt. cap
33,05 mln
Volume
1,14 mln
52-wk high
0,50 US$
52-wk low
0,24 US$
Beta
0,30
Shares outstanding
98,80 mln
No. of employees
70
News stories
From sources across the web
About IGC Pharma Inc
CEO-
Employees70
Founded2005
HeadquartersPotomac, Merilend, Amerika Birləşmiş Ştatları
SectorPharmaceutical industry
Websiteigcpharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
dek 2024
mar 2025
iyn 2025
sen 2025
Revenue
257,00K
330,00K
328,00K
191,00K
Cost of goods sold
153,00K
176,00K
174,00K
92,00K
Cost of revenue
153,00K
176,00K
174,00K
92,00K
Research and development expenses
852,00K
997,00K
851,00K
1,59 mln
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,13 mln
619,00K
1,20 mln
1,41 mln
Operating expense
1,98 mln
1,62 mln
2,06 mln
3,00 mln
Total operating expenses
2,14 mln
1,79 mln
2,23 mln
3,09 mln
Operating income
-1,88 mln
-1,46 mln
-1,90 mln
-2,90 mln
Other non operating income
49,00K
190,00K
306,00K
1,08 mln
EBT including unusual items
-1,83 mln
-1,20 mln
-1,60 mln
-1,82 mln
EBT excluding unusual items
-1,83 mln
-1,27 mln
-1,60 mln
-1,82 mln
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1,83 mln
-1,20 mln
-1,60 mln
-1,82 mln
Net profit margin
-711,67%
-362,73%
-487,50%
-953,40%
Earnings per share
-0,02
-0,01
-0,02
-0,02
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,72 mln
-1,31 mln
-1,76 mln
-2,78 mln
Gain or loss from assets sale
-
-25,00K
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer